Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Damelin

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2007
Hyperconserved CpG domains underlie Polycomb-binding sitesAmos Tanay, Anne H O'Donnell, Marc Damelin, et al.
Cancer Cell|December 13, 2005
Decatenation checkpoint deficiency in stem and progenitor cellsMarc Damelin, Yi E Sun, Veronika Brundula Sodja, et al.
Molecular Pharmaceutics|November 26, 2014
Phenotype of TPBG Gene Replacement in the Mouse and Impact on the Pharmacokinetics of an Antibody-Drug ConjugateGeorge Hu, Mauricio Leal, Qingcong Lin, et al.
Translational Oncology|April 17, 2016
Upregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer CellsKenneth G Geles, Wenyan Zhong, Siobhan K O'Brien, et al.
Nature Reviews. Drug Discovery|October 2, 2009
Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryBin-Bing S Zhou, Haiying Zhang, Marc Damelin, et al.
Cancer Research|September 6, 2015
Breast cancer cells respond differentially to modulation of TGFβ2 signaling after exposure to chemotherapy or hypoxiaSiobhan K O'Brien, Liang Chen, Wenyan Zhong, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2018
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer cocultureShuang Chen, Andreas Giannakou, Sarah Wyman, et al.
Molecular Cell|April 5, 2002
The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stressMarc Damelin, Itamar Simon, Terence I Moy, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Molecular Cancer Therapeutics|December 11, 2012
Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cellsPuja Sapra, Marc Damelin, John Dijoseph, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2007
Hyperconserved CpG domains underlie Polycomb-binding sitesAmos Tanay, Anne H O'Donnell, Marc Damelin, et al.
Cancer Cell|December 13, 2005
Decatenation checkpoint deficiency in stem and progenitor cellsMarc Damelin, Yi E Sun, Veronika Brundula Sodja, et al.
Molecular Pharmaceutics|November 26, 2014
Phenotype of TPBG Gene Replacement in the Mouse and Impact on the Pharmacokinetics of an Antibody-Drug ConjugateGeorge Hu, Mauricio Leal, Qingcong Lin, et al.
Translational Oncology|April 17, 2016
Upregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer CellsKenneth G Geles, Wenyan Zhong, Siobhan K O'Brien, et al.
Nature Reviews. Drug Discovery|October 2, 2009
Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryBin-Bing S Zhou, Haiying Zhang, Marc Damelin, et al.
Cancer Research|September 6, 2015
Breast cancer cells respond differentially to modulation of TGFβ2 signaling after exposure to chemotherapy or hypoxiaSiobhan K O'Brien, Liang Chen, Wenyan Zhong, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2018
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer cocultureShuang Chen, Andreas Giannakou, Sarah Wyman, et al.
Molecular Cell|April 5, 2002
The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stressMarc Damelin, Itamar Simon, Terence I Moy, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Molecular Cancer Therapeutics|December 11, 2012
Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cellsPuja Sapra, Marc Damelin, John Dijoseph, et al.
Pageof 3